Provided by Tiger Trade Technology Pte. Ltd.

Agree

71.23
-0.2600-0.36%
Post-market: 71.230.00000.00%19:52 EDT
Volume:1.41M
Turnover:100.64M
Market Cap:8.86B
PE:38.47
High:71.87
Open:71.87
Low:70.97
Close:71.49
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:1.02
T/O Rate:1.16%
Dividend:3.14
Dividend Rate:4.41%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.40
PE(LYR):40.24

Loading ...

Agree Realty Q2 FFO $1.14 Beats $1.13 Estimate, Sales $204.981M Beat $201.927M Estimate

Benzinga Earnings
·
Jul 31

Agree Realty Q2 Core FFO Per Share USD 1.13

Reuters
·
Jul 31

Agree Realty Corp: Increases 2026 Affo Per Share Guidance to $4.57 to $4.59

THOMSON REUTERS
·
Jul 31

Agree Realty Corp - Raises 2026 Investment Guidance to $1.60 Bln-$1.80 Bln

THOMSON REUTERS
·
Jul 31

Agree Realty Q2 EPS USD 0.44

THOMSON REUTERS
·
Jul 31

Agree Realty Q2 Core Ffo USD 136 Million

THOMSON REUTERS
·
Jul 31

Phase 2 of Kelun Kee Bio's TROP2 ADC Bei Tai La receives NMPA approval for new indications

Stock News
·
Jul 30

Euro Might not Benefit if U.S.-Iran Agree Lasting Peace Deal

Dow Jones
·
Jul 29

VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates

GlobeNewswire
·
Jul 29

Agree Realty Corp Expected to Post Earnings of 47 Cents a Share - Earnings Preview

Reuters
·
Jul 29

BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms

GlobeNewswire
·
Jul 28

Corbus Pharmaceuticals Announces FDA Clearance to Initiate TEMPO-1 Registrational Study of CRB-701 in Patients with 2L Oropharyngeal Cancer

GlobeNewswire
·
Jul 28

Lepu Biopharma’s Claudin 18.2 ADC CMG901 Delivers Positive Global Phase III Gastric Cancer Data

TIPRANKS
·
Jul 28

South Korea, Brazil Agree to Accelerate Mercosur Trade Deal Talks

MT Newswires Live
·
Jul 28

VERAXA Biotech (NASDAQ: VRXA) Advances Bispecific ADC Program Under OmniAb Collaboration

TIPRANKS
·
Jul 28

Adlai Nortye Initiated With Buy on Differentiated RAS-Targeting Pipeline, ADC Strategy and Solid Cash Runway

TIPRANKS
·
Jul 27

Kelun Pharmaceutical's Subsidiary Kelun-Biotech Gets Approval for Clinical Trial of Novel Dual-Load ADC Drug SKB565

Stock News
·
Jul 27

Impact Therapeutics Nominates Preclinical Candidate for GI Cancers

MT Newswires Live
·
Jul 27

IMPACT Therapeutics Unveils First Dual-Payload ADC Preclinical Candidate IMP3201

TIPRANKS
·
Jul 27

Does Agree Realty's Higher 2026 Dividend Payout Reveal a Deeper Capital Allocation Shift for ADC?

Simply Wall St.
·
Jul 26